Is ResMed Stock Underperforming the Nasdaq?

ResMed Inc. (RMD), headquartered in San Diego, California, manufactures, distributes, and markets medical devices and cloud-based software applications. Valued at $36 billion by market cap, the company offers a range of products for respiratory disorders, including diagnostic tools like ApneaLink Air and NightOwl, cloud-based platforms like AirView and myAir for patient monitoring, and U-Sleep for HME providers, connectivity solutions, as well as out-of-hospital software solutions.

Companies worth $10 billion or more are generally described as “large-cap stocks,” and RMD perfectly fits that description, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the medical instruments & supplies industry. ResMed's competitive edge stems from its diversified sleep and respiratory care portfolio, strong brand, and innovation in tech like AI-powered therapy and remote monitoring. With a global presence in 140+ countries, ResMed leverages its strengths to stay ahead.